At AbbVie Contract Manufacturing, readiness is built into the way we work. Explore how AbbVie is translating Annex 1 into action, and setting a new benchmark for compliance and patient safety: hubs.li/Q044NZVz0

There's just one month to go until DCAT Week 2026! From March 23–26, industry leaders will gather in New York to align on what comes next for pharma and biotech. If you’re planning your DCAT schedule, let’s set aside time to talk: hubs.li/Q0457vDH0 #DCATWeek #CDMO

How do you ensure a lyophilized drug is not only stable and effective, but scalable, efficient, and ready for patients? Learn more about our lyophilization services and how we help partners reduce risk, gain speed, and stay inspection-ready. 👉 hubs.li/Q0457tDn0 #CDMO

Poorly soluble drug substances continue to be one of the biggest barriers to effective oral deliver, impacting everything from bioavailability to patient adherence. Want to see how we achieved it? Read the full case study here. 👉hubs.li/Q0457VZr0

A therapy isn’t successful when it’s manufactured. It’s successful when it reaches a patient. Learn more about the manufacturing capabilities that support this journey. 👉 hubs.li/Q046TXqp0 #CDMO #PatientCare #ManufacturingQuality

One week until DCAT Week! If you’re preparing for a concentrated week of discussions, we welcome the opportunity to connect with purpose. Let’s start the conversation: hubs.li/Q046V3Gm0 #DCATWeek #CDMO #PharmaManufacturing

Pharmaceutical manufacturing is being redefined in real time, shaped by evolving modalities, heightened regulatory expectations and an intensified focus on supply continuity. If you’re navigating complex manufacturing decisions, reach out here: hubs.li/Q046T_2k0

The more complex the product, the higher the stakes, and the greater the need for a partner who can manage risk without slowing momentum. 🔗 Explore how we support high-stakes manufacturing: hubs.li/Q047Vswc0 #HPAPI #Aseptic #CDMO #Contractmfg #Biopharma

Global infrastructure is only as powerful as the control behind it. 🌍 It’s how we help partners manufacture at scale, without losing precision or visibility. 🔗 Explore our global footprint and site capabilities: hubs.li/Q048MgfX0

For emerging biotechs, the jump from development to commercial supply can bring new risks: cell-line variability, process drift, and regulatory complexity that can slow momentum. 👉 Explore our biologics capabilities: hubs.li/Q048PPmg0

We are at ARVO 2026 next month! Connect with Ania VanDyke, our Associate Director, Business Development, and Jeff Tremain, our Director of Marketing and Business Development. Book a meeting: hubs.li/Q04b0z0N0

On April 14–15, we will be heading to San Francisco for the American Biomanufacturing Summit. Ready to discuss your path forward? Come and find Jon Best and Tracey Townsend at booth 42 at this year's American Biomanufacturing Summit to talk: hubs.li/Q04b7N0d0

This #FunScienceFriday, we’re exploring why this step is foundational to the medicines patients receive. Swipe below and visit our website to learn more: hubs.li/Q04blc3k0 #DrugSubstance #DrugManufacturing #CDMO

Today is the first day of the American Biomanufacturing Summit, and we're in San Francisco alongside others helping shape the future of biologics manufacturing. Visit us at booth 42 to connect with Jon Best and Tracey Townsend or book a meeting here: hubs.li/Q04bz4hV0

The projected impact of the BIOSECURE Act is prompting a significant re-evaluation of global pharma supply chains and long-term manufacturing strategies. Read the full insight here: hubs.li/Q04bz47J0 #BIOSECURE #SupplyChain #PharmaManufacturing

Poor solubility can stand in the way of a therapy reaching its full potential. Download our case study to learn more about our strategies for improving patient experience with this second-generation tablet formulation: hubs.li/Q04byR4c0

As biologic therapies increase in complexity, the challenge is not only advancing the science, but making sure it can be produced reliably, at scale and with confidence. Click to learn more about Barceloneta: hubs.li/Q04cFW9s0

Antibody-drug conjugates (ADCs) show what targeted therapy can look like when scientific precision and patient purpose come together. Learn more about our approach to ADCs here: hubs.li/Q04cGc4B0

One of the most important shifts in pharmaceutical development happens long before launch, when a promising program begins to advance toward commercial-ready manufacturing. Visit our services page to learn how we can support your therapeutic journey: hubs.li/Q04dwhjM0

Pre-filled syringes (PFS) are more than a packaging format. They are a critical part of how therapies are delivered to patients with safety, accuracy and consistency. Learn more about how we can support your PFS manufacturing journey here: hubs.li/Q04dwcRW0